© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#CROI 2016
Click Here for More Conferences
Click Here for CROI Online
An Introduction to Hepatitis

Conferences

Can You Get Away With an Even Shorter Hepatitis C Treatment?

Research suggests that some people are taking hep C therapy for longer periods than they actually need.

Gilead’s Upcoming Hep C Treatment, Sovaldi/Velpatasvir, Is Safe to Pair With Most HIV Meds

Gilead’s investigational hepatitis C treatment Sovaldi/velpatasvir can be combined safely with most boosted HIV treatments.

Hep C Screening Among Baby Boomers Is Inadequate, And Those With Medicaid Are Less Likely To Be Treated

Despite guidelines calling for universal testing of hepatitis C virus (HCV) among baby boomers, testing rates remain low.

The Big Hepatitis C News Out of the CROI Medical Conference in Boston

A review of important hep C-related medical research presented at a recent medical conference focusing on retroviruses.

Hepatitis C Cure is Linked to Lowered Risk of Death, Kidney Disease and Diabetes in Those With HIV

Curing hepatitis C virus (HCV) is associated with a reduced risk of death, kidney disease and diabetes.

MUST read

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics

Acute Hep C Infection is Linked With Sexual Behavior Among HIV-Positive Gay Men

HIV-positive gay and bi men are more likely to be acutely (very recently) infected with hepatitis C if they have casual sex partners.

Poorly Controlled HIV is Independently Linked to Liver Fibrosis Progression in Those With and Without Hepatitis C

A high HIV viral load and a low CD4 count are each independently linked to liver fibrosis progression among those with and without hep C.

Liver Fibrosis Severity is Tied to Cognitive Dysfunction in Women Independent of HIV or Hepatitis C Status

The severity of liver fibrosis is associated with cognitive dysfunction independent of hepatitis C or HIV status.

A Massive Scale-Up of Hep C Treatment Among Injection Drug Users is Needed to Reap a Prevention Benefit

A massive scale-up of hep C treatment in injection drug users would be required to lower the rate of new infections among the population.

Does Hep C Exposure Raise the Risk of Kidney Disease and Osteoporosis in People With HIV?

A recent study says HIV-positive people who contract hepatitis C have an increased risk of kidney disease and osteoporosis, even if cured.

Hot topics

Forums: Support and discussion
Blogs: The community speaks

Coffee May Reduce the Risk of Death Among Those Coinfected with HIV and Hepatitis C

Drinking at least three cups of coffee a day is linked with a lowered risk of death among people coinfected with HIV and hepatitis C.

Hep C Relapses Are Uncommon Among Those Proclaimed Cured, But Reinfection is a Concern

People with hepatitis C very rarely have a viral relapse after acheiving a sustained virologic response 12 weeks after finishing treatment.

Near Perfect Hepatitis C Cure Rate For Ravidasvir and Sovaldi Among Those With Genotype 4

Sovaldi (sofosbuvir) and ravidasvir, with or without ribavirin, cured almost all people with genotype 4 of hepatitis C in a large trial.

Crystal Meth Use is Strongly Linked to Sexual Acquisition of Hepatitis C in HIV-Positive Gay Men

Among HIV-positive men who have sex with men, crystal meth use is associated with a much higher risk of contracting hepatitis C sexually.

In Real-World Practice, Sovaldi–Based Hep C Regimens Have High Cure Rates Among Those With HIV

Sovaldi (sofosbuvir)–based hepatitis C regimens boast high cure rates in real-world practice among those coinfected with HIV.
Advertisement
Treatment News
Newsfeed
Features
Ask Hep